BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22547594)

  • 1. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials.
    Joosse A; Collette S; Suciu S; Nijsten T; Lejeune F; Kleeberg UR; Coebergh JW; Eggermont AM; de Vries E
    J Clin Oncol; 2012 Jun; 30(18):2240-7. PubMed ID: 22547594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials.
    Joosse A; Collette S; Suciu S; Nijsten T; Patel PM; Keilholz U; Eggermont AM; Coebergh JW; de Vries E
    J Clin Oncol; 2013 Jun; 31(18):2337-46. PubMed ID: 23690423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
    Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
    Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous malignant melanoma of the head and neck.
    Fisher SR
    Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
    Berger AC; Fierro M; Kairys JC; Berd D; Sato T; Andrel J; Hyslop T; Mastrangelo MJ
    J Surg Oncol; 2012 Jan; 105(1):15-20. PubMed ID: 21815149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
    Vihinen P; Vainio-Kaila M; Talve L; Koskivuo I; Syrjänen K; Pyrhönen S
    Acta Oncol; 2012 May; 51(5):662-8. PubMed ID: 22486294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
    Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
    Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.